We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
Cap. Flow
-$120M
Cap. Flow %
-2.42%
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54

Top Buys

Rank Stock Value
1
VTR icon
Ventas
VTR
+$29.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$28.3M
3
ECL icon
Ecolab
ECL
+$25.4M
4
MRK icon
Merck
MRK
+$24.7M
5
EW icon
Edwards Lifesciences
EW
+$20.9M

Top Sells

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$44M
2
SBAC icon
SBA Communications
SBAC
+$43.3M
3
CMG icon
Chipotle Mexican Grill
CMG
+$42M
4
AMTD
TD Ameritrade Holding Corp
AMTD
+$40.5M
5
GILD icon
Gilead Sciences
GILD
+$39.1M

Sector Composition

Rank Sector Weight
1 Healthcare 18.75%
2 Consumer Discretionary 15.42%
3 Technology 15.27%
4 Financials 12.99%
5 Industrials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPSS icon
551
Consumer Portfolio Services
CPSS
$202M
$59K ﹤0.01%
+14,000
New +$60K
GNW icon
552
Genworth Financial
GNW
$3.75B
$55K ﹤0.01%
+20,000
New +$50.6K
AXGN icon
553
Axogen
AXGN
$2.78B
$54K ﹤0.01%
+10,000
New +$50.8K
ECT
554
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$44K ﹤0.01%
30,000
– –
AKS
555
DELISTED
AK Steel Holding Corp
AKS
$41K ﹤0.01%
+10,000
New +$28.7K
PLM
556
DELISTED
PolyMet Mining Corp.
PLM
$41K ﹤0.01%
4,910
-1,000
-17% -$8.32K
VNRBP
557
DELISTED
Vanguard Natural Resources LLC 7.625% Series B Cumulative Redeemable Perpetual Preferred Unit
VNRBP
$37K ﹤0.01%
12,240
-2,150
-15% -$9.77K
BLPH
558
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$31K ﹤0.01%
+833
New +$30.9K
ARNA
559
DELISTED
Arena Pharmaceuticals Inc
ARNA
$20K ﹤0.01%
1,000
– –
MMAT
560
DELISTED
Meta Materials Inc. Common Stock
MMAT
$16K ﹤0.01%
111
– –
EXXI
561
DELISTED
ENERGY XXI LTD COM SHS
EXXI
$16K ﹤0.01%
25,566
– –
DNN icon
562
Denison Mines
DNN
$3.32B
$14K ﹤0.01%
25,000
– –
CMLS
563
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$14K ﹤0.01%
+3,750
New +$9.81K
GPIC
564
DELISTED
Gaming Partners International Corporation
GPIC
$14K ﹤0.01%
1,328,275
– –
BKF
565
DELISTED
BKF CAPITAL GROUP,INC
BKF
$12K ﹤0.01%
17,000
– –
TLOG
566
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$9K ﹤0.01%
+52,471
New +$14.6K
QMM
567
DELISTED
QUATERRA RESOURCES INC LTD
QMM
$6K ﹤0.01%
136,175
– –
GMO
568
DELISTED
General Moly, Inc.
GMO
$5K ﹤0.01%
13,518
– –
ATOS icon
569
Atossa Therapeutics
ATOS
$26.3M
$3K ﹤0.01%
4
– –
BBLU
570
DELISTED
BLUE EARTH, INC. COMMON STOCK
BBLU
$1K ﹤0.01%
30,600
– –
AER icon
571
AerCap
AER
$23.3B
– –
-57,348
Closed -$2.48M
AXP icon
572
American Express
AXP
$226B
– –
-2,915
Closed -$203K
BIIB icon
573
Biogen
BIIB
$32.7B
– –
-9,365
Closed -$2.87M
BTG icon
574
B2Gold
BTG
$7.7B
– –
-11,000
Closed -$11K
CE icon
575
Celanese
CE
$4.92B
– –
-11,308
Closed -$761K
21 22
23
24 25

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.22% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
  • Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
  • Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
  • Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
  • Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
  • Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
  • Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.

Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.